Keywords: bm-s, pharmacopeia, million, alliance, bristol-myers, squibb, drug
BM-S & Pharmacopeia In $40 Million Alliance
Article | 04 December 1997
Bristol-Myers Squibb and drug discovery group Pharmacopeia haveannounced the formation of a three-year research collaboration involving two chemokine receptors related ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
